psilocybin.jpgAnxious and/or depressed cancer patients will receive psilocybin treatment similar to that in Dr. Grob’s study, except that it includes early-stage cancer patients and a different research design.  This study specifically focuses on spiritual experience facilitated by psilocybin as a healing factor in patients suffering from anxiety and/or depression secondary to their cancer diagnosis. It also includes studies of immune system responses to such spiritual experiences, so is also a study about spirituality and physical health. Subject recruiting just begun, and potential subjects can be referred to the study coordinator: See Below.

http://www.bpru.org/cancer/

Advertisements